期刊
LASERS IN SURGERY AND MEDICINE
卷 43, 期 7, 页码 768-775出版社
WILEY
DOI: 10.1002/lsm.21104
关键词
ablative therapy; laser; focal therapy
资金
- Steba Biotech (France)
- Advanced Medical Diagnostics SAS (Belgium)
- USHIFU (USA)
- Prostate Mapping Ltd.
- GSK
- UK National Cancer Research Institute UCLH/UCL Comprehensive Biomedical Research Centre, London, UK
- Department of Urology, University College London Hospitals Trust
- London Deanery
Since the first report of the use of photodynamic therapy (PDT) for prostate cancer in 1990 it has been investigated as a primary and a salvage treatment, using either whole gland or focal approaches. Since 1990 advances in the transperineal approach to the prostate, coupled with photosensitizers which have a short drug-light interval and minimal skin phototoxicity, have resulted in major advances in the field. This review will look at the work done to date, and the ongoing studies which help to define the place of PDT as a useful treatment modality for organ-confined prostate cancer. Lasers Surg. Med. 43:768-775, 2011. (C) 2011 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据